

Publisher: Bentham Science Publishers
E-ISSN: 2212-4063|11|2|87-96
ISSN: 1871-529X
Source: Cardiovascular & Haematological Disorders - Drug Targets(Formerly Current Drug Targets - Cardiovascular & Hematological Disorders), Vol.11, Iss.2, 2011-09, pp. : 87-96
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
The synthesis and antihypertensive activity of a group of imidazo[1,2-a]pyridine is described. New synthesized compound have been tested both in vivo and in vitro as antagonists on Angiotensin AT1 receptor, and compared to Losartan, used as reference drug. Binding assay an Angiotensin AT1 receptor were carried on as well. Compounds 6b and 6g showed a potent antihypertensive activity and an high affinity on AT1 receptor.
Related content








By Riccioni Graziano Vecchia R. Della Di Ilio C. D'orazio N.
Allergy and Asthma Proceedings, Vol. 25, Iss. 6, 2004-11 ,pp. :